Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

A combined strip and FUE method with careful planning improves hair restoration results.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Young Finnish men with more severe hair loss may have higher inflammation and obesity, increasing future heart disease risk.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Some breast cancer chemotherapy can cause permanent hair loss.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Syphilis can cause hair loss that looks like other conditions, but it improves with treatment.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

The hHa7 gene is regulated by androgens in certain body hair, not scalp hair.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Body hair isn't a good substitute for scalp hair in steroid analysis.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Fat cells are important for tissue repair and stem cell support in various body parts.

Hair growth is influenced by various body and external factors, and neighboring hairs communicate to synchronize regeneration.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.